Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Nicorandil for No Reflow in Anterior STEMI
NCT07138508Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Mar 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicorandil in no-reflow phenomenon, sponsored by Ain Shams University. Started Mar 2024; status: completed.
02
Drugs
nicorandil
03
Conditions
no-reflow phenomenon
Beyond the preview
Go deeper on NCT07138508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07138508.